Minimal change nephrotic syndrome in children with intrauterine growth retardation

J N Sheu1, J H Chen

  • 1Department of Pediatrics, Division of Pediatric Nephrology, Chung Shan Medical and Dental College Hospital, Taichung, Taiwan, Republic of China. jimsheu@csh.org.tw

Insights

Intrauterine growth retardation (IUGR) is linked to more frequent relapses and steroid dependence in childhood minimal change nephrotic syndrome (MCNS). Early identification of IUGR can help predict a worse MCNS clinical course.

Area of Science:

  • Pediatric Nephrology
  • Neonatology
  • Clinical Medicine

Background:

  • Intrauterine growth retardation (IUGR) is associated with increased perinatal and adult morbidity/mortality.
  • Minimal change nephrotic syndrome (MCNS) is a common cause of nephrotic syndrome in children.
  • The impact of IUGR on the clinical course of pediatric MCNS is not well-defined.

Purpose of the Study:

  • To investigate whether intrauterine growth retardation (IUGR) influences the clinical course of minimal change nephrotic syndrome (MCNS) in children.
  • To identify potential risk factors for a more severe MCNS presentation.

Main Methods:

  • Retrospective study of 50 children (aged 1-13 years) with MCNS.
  • Diagnosis confirmed by renal biopsy in 50% of cases.
  • Comparison of clinical outcomes between children with and without IUGR (birth weight <10th percentile).

Main Results:

  • Children with IUGR (16% of cohort) experienced significantly more relapses (13.0 vs 3.4) and higher relapse rates (1.6 vs 0.5 per year).
  • 100% of IUGR children developed steroid dependence compared to 21.4% without IUGR.
  • IUGR children had increased use of cytotoxic agents/cyclosporine and a higher incidence of complications.

Conclusions:

  • MCNS in children with IUGR follows a more unfavorable course with increased relapses and steroid dependence.
  • IUGR may serve as an early indicator for identifying children at higher risk for severe MCNS.
  • Consideration of more aggressive therapeutic strategies for MCNS patients with a history of IUGR is warranted.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...